Alumis, Inc. Hits Day High with Strong 7.4% Intraday Surge

Alumis, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in its stock price, gaining 7.4% on July 21, 2026. The stock reached an intraday high of USD 30.11, reflecting a strong performance relative to the broader market, as the S&P 500 only increased by 0.89% on the same day. Over the past week, Alumis has shown a robust 10.15% increase, and its one-month performance stands at an impressive 28.36%. Year-to-date, the stock has soared by 207.89%, significantly outpacing the S&P 500's 9.7% gain. In the past year, Alumis has delivered an extraordinary return of 805.12%, compared to the S&P 500's 19.09%. Despite these gains, the company faces challenges, including a decline in operating profit and negative pre-tax and net profits reported in recent quarters. Additionally, promoter confidence appears to be waning, with a 5.17% reduction in their stake. As Alumis navigates these dynamics, its recent stock performance highlights the volatility and potential risks inherent in the current market environment.